Single Cell Analysis of Cultivated Fibroblasts from Chronic Pancreatitis and Pancreatic Cancer Patients

Yoshiaki Sunami, Yijun Chen, Bogusz Trojanowicz, Matthias Sommerer, Monika Hämmerle, Roland Eils, Jörg KleeffCells 2022 · DOI

TL;DR

This study uses single-cell RNA sequencing to compare fibroblasts from chronic pancreatitis (DAFs) and pancreatic cancer (CAFs) patients, revealing a shared "myCAF-like" subtype and identifying common molecular signatures. These findings suggest that DAFs in chronic pancreatitis may share functional similarities with CAFs in cancer, potentially contributing to disease progression.

What Problem Does This Paper Address?

Pancreatic cancer is a deadly disease, and its dense tumor microenvironment, largely composed of cancer-associated fibroblasts (CAFs), is a major contributor to treatment resistance. While CAFs are known to be heterogeneous and play crucial roles in cancer progression, their specific subtypes and how they differ or overlap with fibroblasts in non-cancerous pancreatic diseases like chronic pancreatitis remain unclear. This paper aims to bridge this knowledge gap by investigating whether the CAF subtypes identified in pancreatic cancer are also present in chronic pancreatitis, and to identify common molecular features between these fibroblast populations.

Methods

The researchers employed the outgrowth method to isolate primary fibroblasts from pancreatic cancer and chronic pancreatitis patient samples. This standard technique involves culturing tissue fragments and allowing fibroblasts to grow out. The key innovation here is the application of single-cell RNA sequencing (scRNA-seq) to these isolated cells. This allows for a high-resolution analysis of gene expression at the individual cell level.

Following scRNA-seq, a series of bioinformatics analyses were performed. This included:

  • Quality control and filtering: Removing low-quality cells and genes.
  • Dimensionality reduction: Techniques like Principal Component Analysis (PCA), t-distributed Stochastic Neighbor Embedding (t-SNE), and Uniform Manifold Approximation and Projection (UMAP) were used to visualize the complex gene expression data.
  • Clustering: The Louvain algorithm was applied to group cells with similar expression profiles.
  • Cell cycle regression: A crucial step to account for the significant influence of cell cycle genes on observed heterogeneity. This process aims to remove cell cycle-associated variability to better identify other biological differences.
  • Identification of highly variable genes: Genes that show significant variation in expression across cells were identified.
  • Gene expression profiling and survival analysis: The GEPIA platform was used to correlate the expression of identified genes with overall survival in pancreatic cancer patients.
  • Immunocytochemistry: Used to validate the absence of epithelial cells (tumor cells) in the isolated fibroblast cultures and to confirm the expression of specific markers like alpha-smooth muscle actin (α-SMA) and CXCL12.

Datasets

The study utilized primary human pancreas samples from patients diagnosed with pancreatic cancer or chronic pancreatitis. The scRNA-seq data generated from these samples were made publicly available through the European Genome-Phenome Archive (EGA) under accession number EGAS00001005889. For survival analysis, data from the Cancer Genome Atlas (TCGA) database was used, comprising 176 to 178 pancreatic cancer samples.

Key Insights and Ideas

  • Shared "myCAF-like" identity: Despite efforts to classify fibroblasts into distinct myCAF, iCAF, or apCAF subtypes, the study found that all isolated fibroblasts, regardless of disease origin, exhibited a gene expression profile resembling a "myCAF-like" subtype. This suggests a common foundational fibroblast identity that might be modulated by disease context.
  • Cell cycle as a major driver of heterogeneity: The analysis revealed that a significant portion of the observed gene expression variability was driven by cell cycle-associated genes. This highlights the importance of accounting for cell cycle effects in scRNA-seq data to uncover true biological differences.
  • Common molecular signatures across diseases: After accounting for cell cycle effects, a substantial number of highly variable genes (135) were found to be shared between fibroblasts from chronic pancreatitis and pancreatic cancer. This points to overlapping molecular mechanisms in these seemingly different conditions.
  • Prognostic potential of specific genes: Several identified highly variable genes (IFI27, KRT18, KRT19, MMP1, MMP3, and NEFL) were associated with shorter overall survival in pancreatic cancer patients, suggesting their potential as biomarkers or therapeutic targets.

Key Results

  • The study successfully isolated and performed scRNA-seq on fibroblasts from three patients: two with pancreatic cancer and one with chronic pancreatitis.
  • Bioinformatics analysis identified numerous highly variable genes in fibroblasts from each patient.
  • Six of these genes (IFI27, KRT18, KRT19, MMP1, MMP3, and NEFL) were found to be significantly associated with shorter overall survival in pancreatic cancer patients.
  • After cell cycle regression, 135 highly variable genes were identified as common to both chronic pancreatitis and pancreatic cancer fibroblasts.
  • Immunocytochemistry confirmed the expression of α-SMA in all fibroblast samples and CXCL12 in some, aligning with a myCAF-like profile.

Limitations and Future Work

The authors acknowledge that the study is limited by a small sample size. They also note that they could not identify distinct myCAF, iCAF, or apCAF subtypes, but rather a "myCAF-like" subtype.

Future work should focus on:

  • Functional characterization: Identifying which of the shared 135 genes play a key role in pancreatic cancer progression.
  • Clarifying pre-isolation similarity: Investigating whether the observed similarities between CAFs and DAFs exist before isolation or arise during culture.
  • In vivo validation: Establishing mouse models with fibroblast lineage-tracing systems to study CAFs/DAFs before and after cell culture, and to verify findings in a more complex in vivo setting.
  • Broader patient cohorts: Expanding the study to include a larger and more diverse patient population to confirm the findings and identify more robust biomarkers.

Summary updated

Abstract

Cancer-associated fibroblasts (CAFs) play a major role in the progression and drug resistance of pancreatic cancer. Recent studies suggest that CAFs exhibit functional heterogeneity and distinct transcriptomic signatures in pancreatic cancer. Pancreatic fibroblasts also form an integral component in pancreatic diseases such as chronic pancreatitis named disease-associated fibroblasts (DAFs). However, intra-tumoral heterogeneity of CAFs in pancreatic cancer patients and their pivotal role in cancer-related mechanisms have not been fully elucidated. Further, it has not been elucidated whether CAF subtypes identified in pancreatic cancer also exist in chronic pancreatitis. In this study, we used primary isolated fibroblasts from pancreatic cancer and chronic pancreatitis patients using the outgrowth method. Single-cell RNA sequencing (scRNA-seq) was performed, and bioinformatics analysis identified highly variable genes, including factors associated with overall survival of pancreatic cancer patients. The majority of highly variable genes are involved in the cell cycle. Instead of previously classified myofibroblastic (myCAFs), inflammatory (iCAFs), and antigen-presenting (ap) CAFs, we identified a myCAFs-like subtype in all cases. Most interestingly, after cell cycle regression, we observed 135 highly variable genes commonly identified in chronic pancreatitis and pancreatic cancer patients. This study is the first to conduct scRNAseq and bioinformatics analyses to compare CAFs/DAFs from both chronic pancreatitis and pancreatic cancer patients. Further studies are required to select and identify stromal factors in DAFs from chronic pancreatitis cases, which are commonly expressed also in CAFs potentially contributing to pancreatic cancer development.
BibTeX
@inproceedings{sunami2022single,
  author = {Yoshiaki Sunami and Yijun Chen and Bogusz Trojanowicz and Matthias Sommerer and Monika Hämmerle and Roland Eils and Jörg Kleeff},
  title = {{Single Cell Analysis of Cultivated Fibroblasts from Chronic Pancreatitis and Pancreatic Cancer Patients}},
  booktitle = {Cells},
  year = {2022},
  doi = {10.3390/cells11162583},
}
Figure